Fertiglobe Valuation

Is FERTIGLB undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of FERTIGLB when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: FERTIGLB (AED2.54) is trading below our estimate of fair value (AED2.89)

Significantly Below Fair Value: FERTIGLB is trading below fair value, but not by a significant amount.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for FERTIGLB?

Key metric: As FERTIGLB is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for FERTIGLB. This is calculated by dividing FERTIGLB's market cap by their current earnings.
What is FERTIGLB's PE Ratio?
PE Ratio26.7x
EarningsUS$214.70m
Market CapUS$5.74b

Price to Earnings Ratio vs Peers

How does FERTIGLB's PE Ratio compare to its peers?

The above table shows the PE ratio for FERTIGLB vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average16.1x
BOROUGE Borouge
17.2x5.7%د.إ74.8b
EMSTEEL Emsteel Building Materials PJSC
28.4xn/aد.إ8.7b
ICL ICL Group
14.4x15.5%US$5.7b
FMC FMC
4.5x-18.3%US$6.8b
FERTIGLB Fertiglobe
26.7x15.7%د.إ21.1b

Price-To-Earnings vs Peers: FERTIGLB is expensive based on its Price-To-Earnings Ratio (26.7x) compared to the peer average (16.1x).


Price to Earnings Ratio vs Industry

How does FERTIGLB's PE Ratio compare vs other companies in the Asian Chemicals Industry?

25 CompaniesPrice / EarningsEstimated GrowthMarket Cap
FERTIGLB 26.7xIndustry Avg. 22.4xNo. of Companies150PE01632486480+
25 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: FERTIGLB is expensive based on its Price-To-Earnings Ratio (26.7x) compared to the Asian Chemicals industry average (22.4x).


Price to Earnings Ratio vs Fair Ratio

What is FERTIGLB's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

FERTIGLB PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio26.7x
Fair PE Ratio22.9x

Price-To-Earnings vs Fair Ratio: FERTIGLB is expensive based on its Price-To-Earnings Ratio (26.7x) compared to the estimated Fair Price-To-Earnings Ratio (22.9x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst FERTIGLB forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Currentد.إ2.54
د.إ3.07
+20.7%
10.5%د.إ3.45د.إ2.60n/a10
Nov ’25د.إ2.72
د.إ3.04
+11.8%
10.8%د.إ3.45د.إ2.60n/a9
Oct ’25د.إ2.60
د.إ3.06
+17.8%
9.9%د.إ3.45د.إ2.60n/a9
Sep ’25د.إ2.61
د.إ3.02
+15.5%
10.6%د.إ3.45د.إ2.59n/a10
Aug ’25د.إ2.45
د.إ3.08
+25.6%
8.7%د.إ3.45د.إ2.59n/a10
Jul ’25د.إ2.42
د.إ3.14
+29.6%
8.7%د.إ3.50د.إ2.59n/a10
Jun ’25د.إ2.42
د.إ3.18
+31.3%
8.8%د.إ3.50د.إ2.59n/a10
May ’25د.إ2.80
د.إ3.26
+16.3%
8.2%د.إ3.51د.إ2.59n/a10
Apr ’25د.إ2.82
د.إ3.31
+17.4%
10.2%د.إ4.00د.إ2.59n/a10
Mar ’25د.إ2.58
د.إ3.37
+30.4%
10.9%د.إ4.00د.إ2.59n/a10
Feb ’25د.إ2.75
د.إ3.47
+26.1%
10.3%د.إ4.00د.إ2.59n/a10
Jan ’25د.إ2.97
د.إ3.66
+23.4%
6.8%د.إ4.00د.إ3.30n/a9
Dec ’24د.إ3.12
د.إ3.71
+18.9%
9.2%د.إ4.35د.إ3.05n/a10
Nov ’24د.إ3.20
د.إ3.78
+18.1%
10.9%د.إ4.35د.إ2.85د.إ2.7210
Oct ’24د.إ3.49
د.إ3.83
+9.9%
8.0%د.إ4.35د.إ3.36د.إ2.6010
Sep ’24د.إ3.43
د.إ3.83
+11.5%
7.6%د.إ4.25د.إ3.36د.إ2.6110
Aug ’24د.إ3.58
د.إ3.79
+5.8%
8.6%د.إ4.25د.إ3.28د.إ2.459
Jul ’24د.إ3.32
د.إ3.88
+16.9%
10.9%د.إ4.50د.إ3.28د.إ2.429
Jun ’24د.إ3.26
د.إ3.89
+19.4%
10.8%د.إ4.50د.إ3.28د.إ2.429
May ’24د.إ3.76
د.إ4.29
+14.0%
21.4%د.إ6.45د.إ3.15د.إ2.809
Apr ’24د.إ4.00
د.إ4.42
+10.4%
18.7%د.إ6.45د.إ3.15د.إ2.829
Mar ’24د.إ3.94
د.إ4.39
+11.4%
20.4%د.إ6.45د.إ2.80د.إ2.589
Feb ’24د.إ4.05
د.إ5.29
+30.7%
11.2%د.إ6.45د.إ4.50د.إ2.759
Jan ’24د.إ4.23
د.إ5.48
+29.6%
11.2%د.إ6.45د.إ4.50د.إ2.979
Dec ’23د.إ4.61
د.إ5.63
+22.1%
9.6%د.إ6.45د.إ4.95د.إ3.128
Nov ’23د.إ5.05
د.إ5.71
+13.1%
9.1%د.إ6.45د.إ5.10د.إ3.208

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies